371 The association of the gut microbiota and clinical response to immune checkpoint inhibitors in patients with advanced cancer

by John Chang, Chiao-En Wu, Cheng-Hsun Chiu, Ming-Mo Hou, Chih-Yu Tsai, Yu-Fen Lin, Yuan-Ming Yeh, Yung–Chi Shen, Jia-Juan Hsieh
Published 2020-11-01

Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A...

by John WC Chang, Ming-Mo Hou, Jia-Juan Hsieh, Yun-Chung Cheung, Hung-Ming Wang, Jen-Shi Chen, Cheng-Hsu Wang, Chih-Hung Chen, Kun-Yun Yeh, Li-Ying Ou, Chia-Hsun Hsieh, Hong-Dar Isaac Wu, Ying-Tsong Chen, Il-Chi Chang, Shiu-Feng Huang
Published 2015-06-01

Immune Checkpoint Inhibitors for Advanced Melanoma: Experience at a Single Institution in Taiwan

by Chiao-En Wu, Chiao-En Wu, Chan-Keng Yang, Chan-Keng Yang, Meng-Ting Peng, Meng-Ting Peng, Pei-Wei Huang, Pei-Wei Huang, Yu-Fen Lin, Yu-Fen Lin, Chi-Yuan Cheng, Chi-Yuan Cheng, Yao-Yu Chang, Huan-Wu Chen, Jia-Juan Hsieh, John Wen-Cheng Chang, John Wen-Cheng Chang
Published 2020-06-01